Next Vial review
Fully online GLP-1 telehealth marketplace connecting patients with licensed providers for compounded semaglutide and tirzepatide injections, including microdose options.
- Scores never bought
- 537 providers tracked
- Every factor auditable
- Updated August 2026
Semaglutide here is $199/mo — almost exactly our category median of $199.
- Semaglutide
- $199/mo
- Tirzepatide
- Not disclosed
- Coverage
- 49 states
- Brand-name
- Compounded only
- Oral option
- Injectable only
- Verification
- LegitScript-certified
Best for: People seeking compounded GLP-1 care with LegitScript certification and a named pharmacy partner.
MatchScript's take: Our #328 pick of 537 — priced at or below the category median.
The factor breakdown
Next Vial on the six Match Score factors — the same sub-scores the quiz reweights to your priorities. See the methodology.
Semaglutide from $199/mo puts Budget Fit at a below-par 55 — above the budget tiers.
Limited or undisclosed state coverage can slow your start, for a solid 86 on Speed to Start.
Next Vial sticks to compounded injectables, for a below-par 53 on Formulary Match.
Support lands at a below-par 72 — lighter, meds-first support.
Flexibility scores a below-par 55 — fewer levers to flex your plan.
LegitScript certification helps, but thin pricing and sourcing detail keeps Transparency at a below-par 46.
Pricing in context
How Next Vial's monthly price sits against the category median and the cheapest provider we track.
What we like
- LegitScript verified with named pharmacy partner (Manifest Pharmacy, Greer, SC)
- No membership fees — one all-in price covering consultation, medication, and shipping
- Compounded semaglutide, tirzepatide, and microdose options available
- Free rushed shipping; serves 49 states nationwide
- Board-certified physician oversight with ongoing provider support
The caveats
- Tirzepatide pricing not listed publicly (starting price covers GLP-1 generally)
- Compounded medications are not FDA-approved
- Labs and nutritional coaching not disclosed
- Microdose pricing not published on product page
- Alaska not listed among served states
Who it's for — and who should skip it
Next Vial is for people seeking compounded GLP-1 care with LegitScript certification and a named pharmacy partner.
Skip it if that doesn't sound like you. A closer fit may be MEDGm (Match Score 60) — or take the quiz to see where Next Vial lands for your priorities.
How it compares to CoreAge Rx & the closest scorer
Next Vial against our #1 overall pick and the provider that scores closest to it. Green marks the row leader.
| How it compares | Next Vialthis provider | CoreAge Rxour #1 | LevelsRxclosest scorer |
|---|---|---|---|
| Sema price | $199/mo | $99/mo at every dose | $253/mo |
| Coverage | 49 states | All 50 states | Coverage not published |
| Formulary | Injectable | Injectable | Injectable + oral |
| Match Score | 61 · C | 91 · A− | 61 · C |
Next Vial, answered
Is Next Vial legit?
Yes — Next Vial is LegitScript-certified, a third-party check that a telehealth pharmacy operates within the rules. Like most programs here it dispenses compounded GLP-1s, which are made by a licensed pharmacy but aren't FDA-approved; confirm your prescriber is US-licensed at intake.
How much does Next Vial cost?
Next Vial lists compounded semaglutide from $199/mo — right at our category median. These are the provider's public figures at our last review (August 2026); confirm on their site, since some teaser tiers step up after month one.
Does Next Vial ship to my state?
Almost certainly — Next Vial reports near-nationwide coverage (49 states). Check the exclusions before you pay.
Next Vial vs MEDGm — which should I pick?
They score within a few points of each other: Next Vial at 61/100 and MEDGm at 60/100, so neither wins on the headline number. Next Vial is the better fit for people seeking compounded GLP-1 care with LegitScript certification and a named pharmacy partner. MEDGm suits people who want four named pharmacies and a fifty-state footprint, and who will click the coupon off before deciding what the program costs. Run the quiz and the weighting shifts to whichever of those matters more to you.
Pricing & state data last verified August 2026 from Next Vial's public site and our master provider matrix. The Match Score and its sub-scores are our editorial judgment per the methodology. Commercial facts only — prices change, so confirm on Next Vial's site. Not medical advice; see our disclosure.
Semaglutide here is $199/mo — almost exactly our category median of $199. It scores highest on how quickly you can start. Best suited to people seeking compounded GLP-1 care with LegitScript certification and a named pharmacy partner. If that is not you, MEDGm is the closest thing to it here.
Compare with other providers
Our next-best picks in default ranking order, then the 24 programs that sit nearest Next Vial here.
- #1Match91/ 100CoreAge RxThe best all-around match: nationwide access, both molecules at one flat, no-surprise price, and an easy exit.91/100
- #2Match84/ 100Strut HealthThe only program here carrying both LegitScript and ACHC accreditation, with an oral lozenge route on both molecules at the cheapest entry in this ranking.84/100
- #3Match83/ 100EdenA polished, high-disclosure compounded program with strong nationwide coverage and hands-on support.83/100
- #4Match85/ 100RoA heavyweight telehealth brand with brand-name access and a polished experience — but opaque compounded pricing.85/100
- #5Match85/ 100No BS RXThe highest Transparency score here, and it is not close: twenty-four prices on one public page and four dispensing pharmacies named with street addresses.85/100
Compare 24 nearby providersHide them
| Provider | Tirzepatide price | Coverage | Alternatives | Go | ||
|---|---|---|---|---|---|---|
| Novi#329 | 61 | $149/mo | $405/mo | Coverage not published | Alternatives | Visit |
| Rewinding RX#330 | 61 | $141/mo | $192/mo | All 50 states | Alternatives | Visit |
| HealthHub#331 | 61 | $100/mo | $202/mo | Coverage not published | Alternatives | Visit |
| Solaya MD#332 | 61 | Not disclosed | Not disclosed | All 50 states | Alternatives | Visit |
| Lttl#333 | 58 | $216/mo | $303/mo | Coverage not published | Alternatives | Visit |
| Fifty 410#334 FDA issued Aspen Aesthetics dba Fifty 410 a warning letter in February 2026. See FDA's warning-letter database. | 60 | $199/mo | $133/mo (starting dose, compounded) | Coverage not published | Alternatives | Visit |
| Ivim Health#335 | 60 | $268/mo | $355/mo | Coverage not published | Alternatives | Visit |
| TeleHealth Med#336 | 60 | $263/mo | Not disclosed | Coverage not published | Alternatives | Visit |
| June Health#337 | 60 | $283/mo | $202/mo | Coverage not published | Alternatives | Visit |
| Neo Soma Healthcare#338 | 60 | $216/mo | $239/mo | Coverage not published | Alternatives | Visit |
| Pomegranate Health#339 | 60 | $129/mo | $149/mo (Starter plan, dose not published, compounded) | Coverage not published | Alternatives | Visit |
| Premium Health#340 FDA issued Premium Health Management Inc. dba Premium Health a warning letter in February 2026. See FDA's warning-letter database. | 60 | $275/mo (all doses, compounded) | $445/mo (all doses, compounded) | Coverage not published | Alternatives | Visit |
| WeightCare#341 FDA issued Weightless Medical LLC dba WeightCare a warning letter in February 2026. See FDA's warning-letter database. | 60 | $399/mo | $499/mo (15 mg dose, compounded) | Coverage not published | Alternatives | Visit |
| 9amHealth#342 | 60 | $149/mo (plus a separate fee, brand-name) | Not disclosed | Coverage not published | Alternatives | Visit |
| Aurelius Health Group#343 | 60 | Not disclosed | $199/mo (microdose tier, compounded) | Coverage not published | Alternatives | Visit |
| CVS MinuteClinic#344 | 60 | Not disclosed | Not disclosed | Coverage not published | Alternatives | Visit |
| Genesis Health#345 FDA issued Genesis Health International Inc. dba Genesis a warning letter in February 2026. See FDA's warning-letter database. | 60 | $178/mo | $228/mo | Coverage not published | Alternatives | Visit |
| PrideRx#346 | 60 | $149/mo (starting dose, plus a separate fee, brand-name) | $299/mo (2.5 mg dose, plus a separate fee, brand-name) | Coverage not published | Alternatives | Visit |
| Oxford's Medical Weight Loss (The Calibrate Clinic)#347 | 60 | $218/mo | $334/mo | 2 states | Alternatives | Visit |
| Vitalex Health#348 | 60 | $199/mo (starting dose, compounded) | $199/mo (starting dose, compounded) | Coverage not published | Alternatives | Visit |
| Harmony Wellness Clinic#349 | 60 | $203/mo | $254/mo | 36 states | Alternatives | Visit |
| Lumora#350 | 60 | $249/mo | $330/mo | Coverage not published | Alternatives | Visit |
| Obu Health#351 | 60 | $193/mo | $242/mo | Coverage not published | Alternatives | Visit |
| Revive Meds#352 | 60 | $374/mo | $466/mo | All 50 states | Alternatives | Visit |
Next Vial is ranked on our best semaglutide providers board, scored on the same six factors as every other provider there.